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Abstract
Background: Funders of health research increasingly seek to understand how best to allocate resources in order to
achieve maximum value from their funding. We built an international consortium and developed a multinational
case study approach to assess benefits arising from health research. We used that to facilitate analysis of factors in
the production of research that might be associated with translating research findings into wider impacts, and the
complexities involved.
Methods: We built on the Payback Framework and expanded its application through conducting co-ordinated case
studies on the payback from cardiovascular and stroke research in Australia, Canada and the United Kingdom. We
selected a stratified random sample of projects from leading medical research funders. We devised a series of
innovative steps to: minimize the effect of researcher bias; rate the level of impacts identified in the case studies;
and interrogate case study narratives to identify factors that correlated with achieving high or low levels of impact.
Results: Twenty-nine detailed case studies produced many and diverse impacts. Over the 15 to 20 years examined,
basic biomedical research has a greater impact than clinical research in terms of academic impacts such as
knowledge production and research capacity building. Clinical research has greater levels of wider impact on health
policies, practice, and generating health gains. There was no correlation between knowledge production and wider
impacts. We identified various factors associated with high impact. Interaction between researchers and
practitioners and the public is associated with achieving high academic impact and translation into wider impacts,
as is basic research conducted with a clinical focus. Strategic thinking by clinical researchers, in terms of thinking
through pathways by which research could potentially be translated into practice, is associated with high wider
impact. Finally, we identified the complexity of factors behind research translation that can arise in a single case.
Conclusions: We can systematically assess research impacts and use the findings to promote translation. Research
they should not assume academic impacts are proxies for© 2014 Wooding et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
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Research funders have more opportunities for invest-
ment in research than they can support. They need to be
able to better understand how best to allocate resources
to achieve maximum value from their funding, and to
justify continued public-funding or charitable support by
demonstrating the payback or full range of impacts from
the research they fund [1,2]. The ‘science of science’ is a
growing field that aims to understand what works in re-
search funding [3,4]. This involves questions such as,
what kinds of research, what kinds of researcher, and
what settings are most conducive to ensuring success of
the full range of biomedical and health research and its
translation?
An increasing number of studies from the knowledge
translation field identify a range of factors as making an
important contribution to encouraging the uptake of evi-
dence [5]. Grimshaw et al. [6] recommend that, in gen-
eral, systematic reviews rather than single studies be
translated. Others, however, focus on the role of re-
searchers disseminating their research, especially when it
is applied research [7]. A review of studies analyzing the
factors associated with nurses’ uptake of research find-
ings reported that there were too few studies to allow
them to draw firm conclusions on the issue of whether
engaging in research led to increased uptake of research
findings [8]. And Tetroe et al. [9] examined the role of
research funding agencies in a range of knowledge trans-
lation activities, but claimed little was known about their
effectiveness. So, generally, from the perspective of stud-
ies of knowledge translation there does not seem to be
much analysis of whether translation is influenced by
factors associated with how research is conducted.
From the perspective of studies that start with the aim
of assessing the impact of research, progress has been
made on identifying examples and assessing the level of
impacts from health research, but usually in the context
of a single country [10-16]. Some of these examples have
systematically explored the comparative impact on
healthcare of different types of research (basic and clin-
ical) and different modes of funding (projects, fellow-
ships etc). Other studies have started with a series of
health policies and systematically identified factors
linked to research use in these cases [17]. However, as
far as the authors are aware, no previous study started
by estimating the impacts from a diverse series of pro-
jects and then worked back from that to identify com-
mon factors among those projects which have high or
low impact. That is what we attempted in the study de-
scribed here. To analyze systematically the full range
of factors that might be associated with the scientific
success of research, and its translation, requires a
series of steps. We aimed to conduct a suite of case
studies to provide a robust assessment of the level ofimpacts achieved by a range of research projects (con-
ducted in a number of different contexts) together with a
description of the processes involved in devising and con-
ducting the research. Key aspects of the impacts identified
in the case studies could then be rated to facilitate an ana-
lysis of the payback achieved and the factors associated
with it.
This study originated as a researcher-driven project.
Therefore, it was necessary to identify a medical field
and gain the support of research funders. The cardiovas-
cular and stroke field was highly appropriate because it
had been the area in which some of the few previous
studies of the science of science had been conducted
[18], and it was an area in which major health benefits
from the application of research-based interventions had
been demonstrated [19]. We put together an inter-
national consortium of funders and collaborators from
Australia, Canada, and the United Kingdom (UK). They
included the English Department of Health, the Canad-
ian Institutes of Health Research (CIHR), and a range of
medical research charities: the National Heart Founda-
tion of Australia (NHFA) (now called The Heart Foun-
dation [of Australia]); the Heart and Stroke Foundation
of Canada (HSFC); the British Heart Foundation (BHF);
and UK Stroke Association. Case studies were under-
taken by teams in each country, with the UK team also
providing overall project leadership and co-ordination.
The resulting Project Retrosight was, therefore, a
multinational study that investigated the payback from a
diverse range of cardiovascular and stroke research pro-
jects, including their translation into policy, products,
practice, and health and economic gain. We have made
available separate reports on the detailed methods used
[20], the full case studies [21] and the policy implications
derived from the study [22]. Here, we draw on some of
the key methods and findings, and analyze the implica-
tions from the study. Furthermore, we subsequently
aimed to enhance the contribution that the study could
make to the field of implementation science by supple-
menting the findings of our original study through ap-
plying a parallel approach to a single case. So, again, we
started with the impact achieved, and aimed to examine
thoroughly the complexities that were involved in the
translation of even a single body of research into policy
and practice. We wanted to uncover the diversity of the-
ories and conceptual discussions that could contribute
to an understanding of the complexities of how various
features of just one original research project interact and
influence the degree of translation achieved.
Methods
We undertook a sequence of activities drawing initially
on existing methods. We adopted successful methodolo-
gies used originally to evaluate health services research
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search funding in diabetes [23], arthritis [11], asthma
[16], and health technology assessments [13,14]. But we
also developed new methods to expand the analysis. Fur-
thermore, to reduce the dangers of researcher bias we
involved, as far as possible, multiple team members in
each stage of the project and incorporated various mea-
sures to increase transparency and reduce the need for
subjective judgements. Here we list the various stages in-
volved in the project, and then describe each in more
detail:
1. Selecting a stratified random sample for case studies;
2. Conducting the multinational set of case studies;
3. Rating payback from each case study;
4. Deriving combined impact categories;
5. Identifying factors that might explain variations in
impact;
6. Developing policy recommendations.
Selecting a stratified random sample for case studies
We opted to focus on project grants/grants-in-aid to re-
strict the variety and scale of funding in our sample.
Lists of projects funded by organizations within the col-
laboration were used to identify a total of 1,347 grants
awarded in our chosen period: 1989 to 1993, a period
which allowed at least 14 years between the start of the
project and the assessment of impacts. These projects
provided a population from which to sample our case
studies. The time period chosen reflected a balance be-
tween the availability of reliable information on projects
and the need to allow enough time to have passed for
research paybacks to develop.
More so than in those previous assessments of re-
search impact which had adopted a purposive case study
selection [11], we wished to increase the likelihood that
our findings could be transferable. We therefore identi-
fied the number of detailed case studies funding would
permit us to conduct, and randomly chose case studies
from our population, but stratified the sample by four
key characteristics:
1. Type of research (basic or clinical – for the purpose
of this project the examples of health services
research were included in the clinical category).
2. Country of research (UK, Canada, Australia)
3. Grant size (large or small)
4. An initial estimate of the level of payback (high or
low) from the project using the brief approach
described below.
Stratifying according to the estimate of payback was
thought to be important to ensure we had a balance of
levels of payback in the case studies. While the eventualcategorization of case studies by the level of payback
achieved did not draw on the original estimates, it was
thought important to attempt to ensure we studied a
portfolio of cases likely to result in different levels of im-
pact. We hoped this would allow us in the eventual ana-
lysis to look for factors shared between higher payback
case studies, but not with lower impact case studies. To
secure an initial estimate of payback we used a web-
based survey that asked Principal Investigators (PIs) a
series of brief questions about impacts arising from their
grants, from the number of papers published to effects
on patient or public health. From their answers we made
an initial categorization of payback for each grant. We
also asked PIs to classify their grants as basic biomedical
or clinical research, according to a standard definition
we provided (and we subsequently conducted a sensitiv-
ity analysis of the basic biomedical-clinical research
categorization provided by the PIs). Separately for each
country, we conducted the random sample selection
from among the project PIs who responded to the sur-
vey. For each country we populated a selection matrix
using the three key characteristics (types of research, size
of grant, and initial estimate of impact). This gave us
eight cells for each country and we randomly selected a
case from each cell.
The Canadian team was able to conduct an additional
four cases, divided between the various categories. As
explained below, one additional case study was under-
taken in the UK leaving the final total of 29 cases as be-
ing 12 Canadian, nine British, and eight Australian. Of
the original 28 researchers selected at random from the
various cells, 22 agreed to participate, but three of these
22 case studies were not completed.a Finding suitable re-
placements contributed to an eventual slight imbalance
in the set of cases: five of the eight Australian cases were
selected from the high impact group, and three from the
low impact group. For the UK there were four selected
from the high impact and five from the low impact. In
Canada there were six in each group. Overall, the bal-
ance between basic (15 case studies) and clinical (14)
was maintained, as was that between cases initially esti-
mated to have high impact (15) and low impact (14),
and between large size (15) and small (14). Nevertheless,
in the basic, small, low impact group we ended up with
just two studies instead of the intended three, and both
of these were from the UK as an additional case was re-
quired in this cell because there was no case study from
Australia or Canada [22].
Conducting the multinational set of case studies
We used a case study approach to provide a rich source
of relevant material [24]. Such an approach has proved
useful when assessing research impacts [25]. We used
the Buxton and Hanney Payback Framework to structure
our case studies [10]. It has two elements: five payback
categories and the payback model. These have been de-
scribed in previous studies [10,13,26] and the five pay-
back categories are listed in the first column of Table 1.
The payback framework provides a common structure
for: examining why the PI applied for the research grant;
the responses of the funding committees; the research
process, including collaborations, use of shared re-
sources, etc; research outputs (e.g., publications); how
those outputs influenced subsequent research topics and
careers; how the research was subsequently translated
into ‘secondary outputs', through influencing clinical
policies or product development; and how the research
then translated into the final outcomes of improvements
in health and broader economic benefits.
The project received ethical approval from the University
Research Ethics Committee of Brunel University.
In each case, we carried out a face-to-face interview
with the PI, which was supplemented by interviews with
other members of the research team, their collaborators,
competitors or practitioners, or policy-makers who used
their work. Where available we reviewed funder documents
Table 1 The impacts in each payback category from the 29 cases, with illustrative examples
Payback category and number of projects achieving some impact Illustrative examples
Knowledge production: peer-reviewed publications. All 29 projects A Canadian project on the determinants of increased growth of vascular
smooth muscle in spontaneously hypertensive rats produced 16 articles -
cited 849 times.
Research targeting and capacity building: Post Graduate research
training; career development of PI and team; transfer of skills;
informing future studies. All 29 projects
An Australian project on high density lipoprotein (HDL) led to: many
collaborations for the PI; advanced the career of the post-doc; new
research techniques; further research funding for the group; and better
targeting of other groups’ research through increased understanding of
HDL. A UK project on the role of coagulation and fibrinolysis in the
pathogenesis of recurrent stroke supported the training of 2 PhDs, an MD
and development of a patient cohort and control group that formed the
basis of a stream of work. It helped the PI establish his research group.
Informing policy and product development: informing a wide range of
policies, including clinical guidelines; informing the development of
therapeutic products, diagnostic tests, etc. 23 of the 29 projects
An Australian project that created animal models for myocardial
dysfunction had contributed to the decision to create a transgenic facility
at the research institute, which later informed the development of a
commercial facility. Guidelines recommend a treatment pathway for
antiphospholipid antibodies based on a Canadian project on warfarin and
thrombosis; work on the follow-on studies informed guidelines for
warfarin therapy. A UK project on the incidence, severity and recovery of
language disorders following right-hemisphere stroke informed: national
guidelines, curriculum development of a speech therapy school, and a
patient leaflet.
Health and health sector benefits: health gains from improved
treatments and public health; more effective use of healthcare
resources; increased health equity. 19 of the 29 projects
An Australian project studying the effects of angiotensin converting
enzyme (ACE) inhibitors provided part of the international literature used
to justify their adoption in the treatment of LV hypertrophy, hypertension,
cardiac disease, etc; there have been major health gains from the
introduction of ACE inhibitors. A Canadian project on nimodipine binding
in cerebral ischemia was part of a stream of work underpinning some of
the Canadian Best Practice Recommendations for Stroke. This study, along
with many others, led to health gains and cost savings through the
administration of tissue plasminogen activator. A UK project analyzing the
results of the Heartstart Scotland initiative to introduce automated
defibrillators into all Scotland’s ambulances informed not only guidelines
b
r
in
T
t
m
p
o
s
s
S
c
in
h
t
Wooding et al. Implementation Science 2014, 9:47 Page 4 of 12
http://www.implementationscience.com/content/9/1/47Broader economic benefits: benefits to the economy such as greater
employment, exports, etc., as a result of commercial development
informed by the research; contribution to a healthier workforce through
a reduction in production lost by mortality and morbidity. 10 of the 29
projectsw
Source: Adapted with permission from Table S.1 of Wooding et al. (2011) [22].ut also the policy of ambulance services in Scotland and England. As a
esult it has made an important contribution to health gains through the
creased survival rate following out-of-hospital cardiac arrest.
he commercial transgenic facility developed in Australia as a result of
he animal models for myocardial dysfunction described above is now a
ulti-million dollar business that exports 80% of its services. A Canadian
roject on coronary lesions and vasoactivity in salmon led on to a body
f work that contributed to the literature showing farmed salmon are a
afe source of human dietary omega-3 input, thus contributing to
ustainable aquaculture. A UK project on fibrillin deficiency in Marfan
yndrome (a condition affecting perhaps 18,000 people in the UK alone)
ontributed to international research that improved diagnostic tests and
forms preventive management that pushed the average age of death
igher and most of this health gain is among people of working age;
herefore a number of people have been able to remain active in the
orkforce.
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reviewed PIs’ publications from the grant period.
Alongside the local case study research we undertook
bibliometric analysis. Working with the PIs we identified
and agreed papers that were directly related to the re-
search undertaken using the grant funding, in addition
to those that were indirectly related. We centrally exam-
ined those identified papers that were indexed in ‘Web
of Science’ and analyzed their citations.
Each country had its own team of case study re-
searchers. To establish consistency across the teams, we
held three workshops, provided templates for interview
schedules and write ups, and two members of the UK
team reviewed all initial drafts. To ensure historical ac-
curacy the case studies were validated by the PIs and
underwent external peer review. We attempted to have
each case study reviewed by two experts in the field of
the case study’s research—one from the same country as
the case study and one from a different country. In the
end, 24 case studies were double (or in two cases triple)
reviewed, and five cases single reviewed. These reviews
were used in the next step.
Rating payback from each case study
We then used the 29 detailed case studies of research
grants to identify and understand factors associated with
payback. To do this, we needed to determine which of
our case studies had high payback and which low, so we
could look for factors shared by the high payback cases
and not shared with the others. We have previously
made progress with quantifying the paybacks recorded
in a set of case studies, but we had recognized limita-
tions in our methods [11,13,14]. For this study, we re-
cruited an evaluation panel of nine members (see
Acknowledgements) that included a member of the re-
search team from each country and also independent ex-
perts. We provided them with tables summarizing the
case study narratives and payback, the bibliometric ana-
lysis, and the peer reviewers’ comments on the case
studies. We also made the full case studies and peer re-
view comments available. We did not provide the panel
with information on the PIs’ initial payback estimates, as
we wanted an independent quantification of payback
based on our case studies.
We asked the panel to provide a relative rating of the
payback from each case study in each payback category—
that is, five ratings per study: knowledge production; re-
search targeting and capacity building; informing policy
or product development; health and health sector bene-
fit; and broader economic benefit. Each rating was on a
scale of 0 to 9, where 0 was no payback, 1 was the least
payback in the set of case studies and 9 the most: tied
ratings were allowed. Each panel member provided an
initial set of ratings: these showed a considerable levelof agreement. We then brought them together for a
two-day workshop in which we discussed the ratings
over which there was most disagreement, and then
allowed the panel to rate the case studies a second time.
The aim of the workshop was to eliminate differences
due to differential understanding of the data provided,
but to preserve differences that reflected different
judgements about the relative value of the paybacks. We
carried out a number of tests and analyses of the rating
data, which gave us confidence in the robustness of me-
dian values that we used subsequently. (For details see
the Methodology Report [20]).
Deriving combined impact categories
We looked for correlations between the various cat-
egory ratings and used these to simplify the five payback
ratings into two summary measures. The results of this
analysis led us to combine the first two and the last
three payback categories to produce two mutually ex-
clusive groupings. These two combined impact categor-
ies were academic impact (encompassing knowledge
production, research targeting and capacity building)
and wider impact (encompassing informing policy and
product development, health and health sector benefit,
and broader economic benefit). The two categories, aca-
demic and wider impact, were used in the subsequent
analysis.
Identifying factors that might explain variations in impact
To identify factors associated with impact we used our
two impact categories—academic and wider—separately.
For each, we ordered case studies into three groups—
high-, mid-, and low-impact. High- and low-impact
groups could then be compared to a series of binary var-
iables representing the presence or absence of each fac-
tor in each case study. (We left a mid impact group to
ensure that we had a clear distinction between high and
low impact cases).
To identify factors associated with impact, we exam-
ined the full case studies, coding the presence or absence
of factors using NVivo. We identified an initial list of
factors from our background knowledge and through
discussions at the project and rating workshops. We also
added factors that seemed of interest when we reviewed
the case studies. We tackled the coding process by work-
ing initially with one-half the case studies. Two members
of the research team, working independently, took the
high-impact cases and looked for common factors. They
then compared notes to identify factors both had ob-
served. Two further members of the research team did
the same for the low-impact case studies. The research
team then came together and all the factors were
reviewed and clarified. We then addressed the cases that
had not yet been examined, using the finalised list of
factors, and revised the analysis of the initial cases in
light of the refined list. Finally, each factor was analyzed
quantitatively and qualitatively. To carry out quantitative
analysis, we looked at the balance of the factor’s occur-
rence across high, mid, and low academic and wider im-
pact case studies. We used the Fisher Exact test to give
us an estimate of the relative strength of the associations
extent of research paybacks associated with the grants,
and provides illustrative examples.
Variations between the impacts from basic biomedical
and clinical research
All the grants studied had academic impact. For the com-
bined wider impact categories all clinical studies had some
arc
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ciations between the variables. For qualitative analysis,
we assigned each factor to a coder who reviewed all the
occurrences of each theme to ensure consistency of
interpretationb.
Developing policy recommendations
We presented our initial list of factors associated with
impact at an ‘Emerging Findings Workshop’ in London
in April 2010 attended by members of the research col-
laboration and a number of policymakers and evalua-
tors from organizations funding cardiovascular and
stroke research and wider health research, from the UK
and overseas. The workshop highlighted a number of
areas for further analysis and helped refine our think-
ing. Taking these suggestions into account and drawing
on the contextual knowledge of the research team, we
developed our observations into policy recommendations.
Understanding the complexities of implementation
We subsequently built on the detailed work conducted
originally. We identified a study that had had consider-
able impact in a number of categories. We reviewed
those various examples of impact, and separated out the
various translation pathways through which the diverse
impact had been achieved. We then drew on the team’s
accumulated knowledge (supplemented by a brief select-
ive review) and identified existing theories and concep-
tual perspectives that might illuminate the diverse
processes involved in this case, and features of the re-
search that might have contributed to its translation.
Results
The cases reveal that a significant number and diverse
range of impacts arise from the 29 grants studied
The 29 case studies are presented in a full case study re-
port [21]. Table 1 provides a summary of the range and
Table 2 Mean rating by payback category and type of rese
Payback category
Knowledge production
Benefits for future research and research use
Informing policy and product development
Health and health sector benefitsBroader economic benefits
Each case study was rated for each payback category by all of the 9 raters on a scaimpact, compared to only nine out of 15 basic biomedical
case studies. This is a substantial and statistically signifi-
cant difference. The finding may be confounded by the
longer time lags that are typically required for basic bio-
medical research to achieve wider impacts. Nevertheless,
Table 2 clearly indicates that, the basic biomedical re-
search projects have had a greater academic impact and
clinical research a greater wider impact over the time-
scales studied.
No correlation between knowledge production and wider
impacts
Table 3 shows that overall there is no significant correl-
ation between the payback category ‘knowledge produc-
tion’ and the three wider categories, ‘informing health
policy and product development,’ ‘health and health sector
benefits’ and ‘broader economic benefits.’ The data from
the table were used to produce the two combined categor-
ies of ‘academic impacts’ (i.e. Knowledge production; Re-
search targeting) and ‘wider impacts’ (i.e. Informing policy
and product development; Health & health sector benefits;
Broader economic benefits).
Factors associated with high and low impacts
The full analysis identifies a number of factors in cardio-
vascular and stroke research that appear to be associated
with higher and lower academic and wider impacts. Here
we focus on three of the most clear-cut findings that re-
lated to translation of the research into wider impacts
(and sometimes there was high academic impact as well).
All three provide empirical evidence on issues that are
seen as important for the translation of research and a full
account can be found in the project’s policy report [22].
Other factors we identified showed a link with achieving
high academic impact but not high wider impact, however,
it is not thought relevant to describe them here.
h
Basic biomedical research Clinical research
5.4 4.4
5.3 4.6
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1.9 4.01.1 1.2
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with high academic impacts and high wider impacts
A track record of engagement with practitioners and pa-
tients was defined broadly indicating that the PI had
interaction with either group in a way relevant to the
planning or organization of the research project, or to
achieving impacts, and not simply involving patients in
trials or studies. Such collaboration with practitioners
and patients was more a feature of clinical than of basic
biomedical research. Ten out of 14 clinical case studies
showed this kind of collaboration, but only 2/15 basic
biomedical studies. The correlation between high impact
and engagement with practitioners and patients covers
both types of impact: academic and wider. All high aca-
demic impact case studies on clinical research (6/6) in-
volved engagement with practitioners and patients,
compared to 1/4 for low academic impact case studies.
Similarly, all high wider impact case studies (5/5) in-
volved engagement with practitioners and patients, com-
pared to 2/4 for low wider impact case studies. Both the
basic biomedical research projects with a track record of
collaboration with practitioners and patients achieved a
high rating for wider impact. Whatever the cause and ef-
fect, it is clear from our case studies that some re-
searchers had made considerable efforts to engage with
practitioners and patients, and promote the impact of
their research. For example, one of the case studies said
of the researcher whose research impact was the focus
of the study: ‘As a leading clinician in this field, and
Medical Advisor and Director to the UK patient and re-
Table 3 The correlations between ratings in each payback
Knowledge
production (KP)
Research
targeting (RT)
Informing p
develop
KP 1
RT 0.53 1
IPPD 0.13 0.32
HHSB 0.12 0.39
BEB −0.05 0.23
Coefficients in bold italics are significant at a 0.01 level Spearman’s rho and 2-tasearch organizations, X was well placed to provide ‘offi-
cial', research-informed advice for clinicians and patients’.
Strategic thinking by clinical researchers is associated
with high wider impacts
We defined strategic thinking by clinicians as having oc-
curred when there was evidence in the case study that
the research team had thought through the pathways by
which research could potentially be translated into prac-
tice. This was identified through the analysis of the text
in relevant sections of the case studies, such as those
where we reported on researchers answers to questions
about why they had applied for the research, and whatgaps it might fill. There is some evidence that thinking
through the translation and application of clinical re-
search is associated with wider impact. All (5/5) high
wider impact case studies on clinical research had evi-
dence of strategic thinking by the PI, compared to 1/4
low wider impact case studies on clinical research.
Basic biomedical research with a clear clinical motivation
is associated with high academic impacts and high wider
impacts
We considered that clinically motivated basic research
occurs when there is evidence in the case study that the
research team has a clearly articulated clinical endpoint
and/or is explicit in the case study about their clinical
motivation. All high academic impact case studies on
basic biomedical research (5/5) demonstrated a clinical
motivation, compared to 2/6 low academic impact case
studies. Similarly, all high wider impact case studies on
basic biomedical research (5/5) demonstrated a clinical
motivation, compared to 3/6 low academic impact case
studies.
For the five high academic and wider impact case
studies on basic biomedical research, three of the re-
searchers had a clinical qualification, although they de-
scribed their research as being basic biomedical; this was
confirmed in the sensitivity analysis of the basic
biomedical-clinical research definitions that was con-
ducted. In such cases, motivation can be explained by
the researchers’ clinical background, as remarked by
some of the PIs: ‘The product you see is not just a clin-
egory
cy & product
nt (IPPD)
Health & health sector
benefits (HHSB)
Broader economic
benefits (BEB)
9 1
6 0.52 1
significance; n = 29c.ician; it is a clinician with a strong background in the
laboratory’.
Understanding the complexities of implementation
We identified ‘Heartstart Scotland’ – analysis of the re-
sults of a national programme [21], as a project that had
had considerable impact in several categories. The pro-
ject studied in the case study was itself an evaluation of
the results of the Heartstart Scotland initiative to intro-
duce automated external defibrillators (AEDs) into all
Scotland’s ambulances. We explored the pattern of
translation pathways through which the diverse impacts
were achieved, and identified a complex pattern of at
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piece, or stream, of research. We then identified that
there was one, or more, different existing theories or
conceptual discussions that we could link to each trans-
lation pathway. This is shown on Table 4.
Discussion
It is likely that many of the paybacks identified in Project
Retrosight would not have been identified without the
structured, case study approach used in this study; an
observation that resonates with the diversity of payback
identified in earlier studies on arthritis research and on
asthma research [11,16]. However, it is significant that a
large number and diverse range of paybacks were found
from this random stratified sample of 29 case studies
across three countries. Various previous studies have
identified the (sometimes considerable) impacts from
health research, but have used either a purposive case
study selection approach [10-12,16] or were randomly
selected from a program of research, such as the Na-
tional Health Service Health Technology Assessment
program in the UK, where wider impacts might be ex-
pected [13].
The study found, however, that considerably fewer
projects resulted in broader economic impacts than had
informed health policy or product development. Simi-
larly, it demonstrated the variation between the impacts
achieved by different types of research, with basic bio-
medical research producing higher levels of academic
impact and clinical studies resulting in higher levels of
wider impact. Before considering some of the policy im-
plications of our study we explore some of the project’s
strengths and weaknesses.
Strengths and limitations
To be able to advance thinking in the area of under-
standing scientific success and translation required a
complex set of steps, a range of methods, and consider-
able methodological innovation. We took an existing ap-
proach for assessing impact that has been applied in
various single countries, and applied it in a common
way across three countries giving us a larger number of
diverse case studies than in most previous studies. Fur-
thermore, the use of the payback framework encouraged
consistency across cases and facilitated comparative ana-
lysis. Training and quality assurance checks were under-
taken to enhance consistency across an international
team and these covered both quantitative and qualitative
case study material, and we used standard strategies to
ensure rigor. We used a two-stage process with a diverse
but expert panel of nine to rate the levels of impact by
category for each project. All this contributed to provid-
ing us with a comparatively large and robust dataset to
which we then applied a series of new approaches tomake progress in understanding factors associated with
high (and low) payback.
The limitations of the analysis include issues common
to many projects based on case studies: the number of
cases studies was still only 29; despite our efforts we
cannot exclude the possibility that there may have been
inconsistencies between projects or countries in case
study reporting; and despite attempts to address them,
there may have been confounders of which we were un-
aware. With a limited number of case studies some dif-
ferences between groups of studies reported and
discussed here could have arisen by chance. Because of
this, we have been deliberately cautious in interpreting
our data and have tested the strength of any associations
leading to policy observations. We are also aware that
the wider research translation literature covers many is-
sues that were outside the scope of this study, given its
primary focus on aspects of the production of research
that might be relevant for its translation.
Policy implications
There are policy implications for health research funders
of the findings that while both types of research produce
a wide range of benefits, within a time period of 15 to
20 years it is likely that basic biomedical research will
produce more of the traditional academic impacts, and
clinical research will produce more wider impacts, par-
ticularly on health policies and health gain. Importantly,
we found that the level of knowledge production was
not a predictor of wider impacts. While it is important
to remember the caveat about the time lags often in-
volved before wider impacts arise, this finding does at
the very least mean that any health research funder
wishing to demonstrate that it is achieving wider im-
pacts should not use academic impacts as a proxy for
that.
From a funding viewpoint, the findings about the ben-
efits from researcher engagement with patients and
practitioners are consistent with the claims in the litera-
ture that researchers who want their work to have some
influence on users are more likely to be successful if they
collaborate in some way with them, as described in pre-
vious assessments of impact [10,12,13,15,17], and in the
theories, reviews, and conceptual discussions described
in Table 4 [27-33]. This would suggest that research fun-
ders should encourage and support clinical researchers
who have a record of engaging with practitioners, pa-
tients, and managers in the healthcare system or who
can demonstrate a clear intention of so doing.
The data about strategic thinking suggest there are ben-
efits when clinical research is undertaken by those able
and willing to think about its potential translation into
clinical practice or policy. This may have relevance to ini-
tiatives to include discussion of potential translation in
Table 4 Understanding the complexities of research implementation: analyzing the translation pathways in the
Heartstart Scotland case study
Examples of impact identified in the
Heartstart Scotland evaluation case
study [21]
Description of the how the complex pattern
of impacts was achieved in the Heartstart
Scotland case study: the diverse translation
pathways
Examples of the variety of existing theories
and conceptual discussions that can be
linked to the diverse translation pathways
There was a regular flow of audit and research
data from this evaluation of all attempts at
defibrillation made by Scottish ambulance
crews. The AEDs had originally been introduced
through the Heartstart Scotland initiative led by
the BHF and that raised funds from members of
the public. The evaluation data made an impact
on the management decisions of the Heartstart
Scotland program in a formative way, and
probably had some influence on the decision to
renew the AEDs in Scotland from Scottish Office
(ie Government) funds. While the main credit for
the increased survival following out-of-hospital
cardiac arrest should be allocated to Heartstart
Scotland program itself, the various decisions
that were informed by the evaluation also made
an important contribution.
The research was translated through the close
involvement of key figures from the Scottish
Ambulance Service in all aspects of the research
project. Also, the project PI, Prof Stuart Cobbe,
chaired the evaluation sub-committee for the
Heartstart Scotland program and from 1992
chaired the Professional Advisory Group to the
Scottish Ambulance Service. (Cobbe had also
played a role in encouraging the adoption of
AEDs in the Scottish Ambulance Service in the
first place). Furthermore, members of the
research team regularly consulted with
ambulance crews who had to provide the data
for the evaluation.
This case provides a strong example of the
benefits of the collaborative approach between
health researchers and potential users: such
analysis was developed in the 1970s and 80s by
Kogan and Henkel [27] and increasingly
confirmed in later reviews and analyses [28-32].
This example goes further than just standard
collaborative approaches and provides a rarer
example of how ‘Linkage and Exchange’ [33]
can successfully work in practice. The Linkage
and Exchange concept goes beyond
collaboration on research agendas, and
suggests there should be a continuing
involvement by potential users in the research
project, which was the case in this example.
Within Scotland, Cobbe could be considered a
‘product champion,’ but the wider application
of this term is discussed below in relation to
adoption outside Scotland.
The evaluation continued with further funding
from the Scottish Office and, especially, the BHF.
The evaluation demonstrated that benefits from
the intervention (ie introduction of defibrillators
at a system level) were maintained. Such
maintenance of a high level of benefits
compares favourably with other examples of the
introduction of comparable initiatives that were
not accompanied by continuing evaluation
research [34]. It was suggested in the case study
that the continuing evaluation contributed to
the continuing high levels of benefit from the
introduction of AEDs.
Several aspects of this case, while not common,
provide an interesting example of how the
sustained research funding could be linked to
the sustainability of the impact of an
intervention. A key reason why the same project
continued for so long, and established possibly
the most significant database on out-of-hospital
defibrillation in any country, was the
incorporation of the funding for the project into
the long-term funding provided for Cobbe
through his BHF Chair funding. The continuing
links between the research team and the users
in the Scottish Ambulance Service, would
probably have contributed to the continued
benefits from the introduction of AEDs.
In setting an agenda for Implementation
research Eccles et al. (2009) set out the
importance of sustainability: ‘Within research
itself it is important to examine attributes of
sustainability (within individuals, teams, and
organizations) and to develop methods to
examine whether the effects of interventions
are sustained over time.’ ([35]: p.5) Sustainability
continues to be included in taxonomies of
implementation outcomes [36]. The chair
funding was very important in this case, and
this form of long-term funding is increasingly
being shown to assist with the ability to pursue
ideas in a way that can contribute either to
sustainability of initiatives, or promotion of ideas
that might take a long period before they come
to fruition [16].
The research almost certainly contributed to the
decisions of some ambulance services in the UK
and elsewhere to introduce AEDs.
This was probably caused by several factors,
including the role of Dr Douglas Chamberlain, a
leading national and international figure in the
field of resuscitation, who was a pioneer in the
use of defibrillators. In his active promotion of
AEDs, he frequently drew on the Heartstart
Scotland study; Chamberlain believed the study
to be a very careful evaluation. The quality and
credibility of the study might therefore have
been important in the willingness of
Chamberlain to draw on it so heavily. Cobbe’s
research ranged from basic research, including
on the electrophysiology of the heart, through
to health services research such as this
evaluation. The case study noted other
examples where researchers who conducted a
wide spectrum of research could sometimes
transfer understandings [23].
Various theories of implementation identify the
role that can be played by ‘product champions’
in promoting an innovation [37]. This can be
seen as going even further than the role of
opinion leaders first demonstrated in the
healthcare field by Coleman et al. (1966) [38]
and elaborated in the description of ‘expert’
opinion leaders by Locock et al. (2001) [39].
While in this case the innovation Chamberlain
was promoting was the actual introduction of a
system of defibrillators, his activities contributed
considerably to the impact made by the
Heartstart Scotland evaluation project, because
he frequently quoted this evidence when
making the case for defibrillators. His willingness
to do so seems to have been influenced by the
nature of the evaluation research.
The research made a considerable impact on
guidelines of many leading and local
organizations in the resuscitation field from
1992 onwards. In relation to a range of issues,
and in a number of resuscitation-related
guidelines and educational and training
programmes, papers from the Heartstart
Scotland evaluation project were used as the
The publications and conference presentations
from the PI and other team members played a
major role in transferring the findings to
potential users beyond those directly involved
in the project. The team’s dissemination
activities were picked up very widely by many
organizations. These included ones with whom
the research team had links, eg the European
Dissemination of work is increasingly viewed as
a major responsibility of researchers: Wilson
et al. (2010) reviewed conceptual frameworks
designed for use by researchers to guide
dissemination and concluded that most applied
health research funding agencies expect some
effort on the part of researchers to disseminate
their findings [7]. The direct impact of this single
Wooding et al. Implementation Science 2014, 9:47 Page 9 of 12
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http://www.implementationscience.com/content/9/1/47research applications, and suggests that it may well be
appropriate that UK Research Councils, for example,
have been encouraging researchers to think strategically
and require them to describe potential ‘Pathways to Im-
pact’. Funders should also consider what mechanisms
they might be able to use to assist researchers to con-
sider ways to maximize the potential for research to be
translated. But the findings also highlight that research
funders and governments more generally should realize
that most biomedical and clinical projects are unlikely
to produce significant economic benefits within a period
of 15 to 20 years. Perhaps along similar lines, the find-
ings about basic research with a clinical motivation be-
ing associated with high impact, at least in the time
period over which this study was conducted, are find-
ings that funders should consider in relation to their
portfolios of research and the timescales over which
they hope to make an impact. This also correlates with a
previous study of research on diabetes [23].
The full policy implications are set out in the project’s
Table 4 Understanding the complexities of research implem
Heartstart Scotland case study (Continued)
main evidence, or as one of a small
number of supporting papers.
Resuscitation Committe
whom the research tea
direct links. Much of th
to the findings being in
meta-analysis in 1999 [4
papers from the researc
be cited on guidelines
The research made a considerable
impact on the meta- analysis published
in 1999 on the effectiveness of
defibrillator-capable emergency
medical services for victims of
out-of-hospital cardiac arrest [40].
The Heartstart Scotland
biggest contribution to
papers, Heartstart contr
the patients, more than
[40]. This again illustrate
the follow-on funding t
to continue.policy report [22], but this selection of key points under-
lines the significant contribution that ‘science of science’
studies can make to providing an evidence-base to better
inform the decisions to allocate funding that health re-
search funders have to make. It would be helpful to see
such analysis explored in further case studies and in
other areas of health and related research and therefore
potentially strengthen the validity of the findings, and
develop further the evidence-base for research-funding
policy. Furthermore, our findings on Table 4 provide a
powerful lesson in the complexity of achieving, and
hence also studying, research implementation. They
identify the range of impacts that can come from a sin-
gle case, the diverse translation pathways involved, and
the extent to which these pathways can be conceptua-
lised and associated with the nature of the research itself
and how it was conducted. This reinforces the view that
further work in this field would be beneficial so as todevelop a fuller understanding of the diverse and inter-
acting processes that contribute to research translation.
Conclusions
Previous studies of knowledge translation, and of re-
search impact, tend not to focus on the aspects of re-
search production that might contribute to research
implementation. Yet research funders face more oppor-
tunities for investment in research than they can sup-
port. They need to be better able to understand how
best to allocate resources to achieve maximum value.
We built on the Payback Framework and expanded its
application through conducting a multinational study
consisting of 29 co-ordinated case studies on the pay-
back from cardiovascular and stroke research in
Australia, Canada, and the UK. Then we devised a series
of innovative steps to first rate the level of impacts iden-
tified in the case studies, and second to interrogate the
full case study narratives to identify factors that corre-
lated with achieving high or low levels of impact.
ntation: analyzing the translation pathways in the
and others with
appeared to have no
pact occurred prior
rporated into a
, and the specific
team continued to
er 1999.
study raises key issues in the implementation
field. Grimshaw et al. 2012 suggest ‘the basic
unit of knowledge translation should usually be
up-to-date systematic reviews or other
syntheses of research findings.’ [6]: p.1 In this
case, however, the impact achieved before the
publication of a systematic review was an
important contribution.
tabase made the
e review: out of 37
ted one third of
ouble next highest
he impact made by
t allowed the project
This case study demonstrates the complexity
of ways in which even a single stream of
research might be translated, and that making
a major impact on a meta-analysis might be
important, but might just be one part of a
much broader picture.We found that over the 15 to 20 years examined, basic
biomedical research has a greater impact than clinical
research in terms of academic impacts such as know-
ledge production and research capacity building, but
clinical research has the greater impact on health pol-
icies, practice, and generating health gains. There is no
correlation between knowledge production and wider
impacts. We identified a range of factors associated with
high impact, at least within the timescales considered.
Interaction between the researcher and practitioners and
the public is associated with high academic and wider
impacts, as is basic research with a clear clinical motiv-
ation. Strategic thinking by clinical researchers is associ-
ated with high wider impact.
Research funders can justify funding research of di-
verse types, but should not assume academic impacts
are a proxy for wider impacts. They should encourage
researchers to engage potential research users in the
and Stephen Hanney. The case study bibliometric analysis was coordinated
2011, 6:1.
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http://www.implementationscience.com/content/9/1/47research process, and do what they can to assist re-
searchers consider pathways towards impact. They
should also, where relevant, consider the finding that
basic research proposals that have a clear clinical motiv-
ation seem, at least in a 15 to 20 year timescale, more
likely to make a wider impact. Finally, the complexities
illustrate that, while health research is clearly shown to
be making a considerable impact, there is still much to
learn in this field about the most productive combin-
ation of approaches to use to enhance the chances of
maximizing the impact.
Endnotes
aIn one of the three cases, it transpired that the grant
did not meet our inclusion criteria, in another study in-
sufficient evidence was available to allow full completion,
and in the third the researcher had moved to Japan [22].
bWe eventually decided not to attempt any analysis
based on grant size as the range of sizes turned out to be
relatively small, differed between countries and was not al-
ways correctly reported in funders’ records [22]. Similarly,
we do not include any country comparisons because of
concerns that any differences between scores for countries
might have been a reflection of the fact that each country
had its own specific team to conduct the cases, and des-
pite our attempts to ensure consistency in the conduct of
the cases, some differences might have emerged.
cWe checked two statistical approaches: our initial ap-
proach of using all 261 ratings, as described in the report
[22]; and a possible alternative of using the 29 median
values to calculate the r values. In Table 3 we present the
findings from using the latter approach. We found that in
terms of the conclusion we draw-i.e., the grouping of the
categories-the method used for the test does not affect the
conclusion. Using all the 261 ratings ensures we don’t lose
data, but probably overestimates the n because they are
not fully independent observations; but using the medians
may overestimate the magnitude of the correlation be-
cause it excludes the outlying observations.
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